Join
Live feed
·
INSIDERFilingvia Quantisnow
Lyra Therapeutics Inc. logo

Waksal Harlan bought $74,095 worth of shares (25,000 units at $2.96), increasing direct ownership by 11% to 261,966 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
LYRA· Lyra Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track LYRA (Lyra Therapeutics Inc.) and more on Quantisnow.